Abstract
Non-left main coronary artery disease is a common coronary artery disease, and about 1/5 patients need percutaneous coronary intervention (PCI). This article reviews the advantages, safety and limitations of using bioabsorbable stents in clinical treatment of non-left main coronary artery disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
